Medical device for the treatment of Raynaud’s phenomenon
A novel therapeutic device that applies blue light and warmth for the treatment of Raynaud’s phenomenon.
Technology No. 20180346
1
2
IP Status: US Patent Issued; Patent No. 11,865,357
Prototype in development.
Applications
- Treatment of Raynaud’s phenomenon
- Non-pharmaceutical vasorelaxation
Technology Overview
Raynaud’s phenomenon is a rare disorder that causes arteries to spasm leading to reduced blood flow in areas such as the fingers and toes. Currently, treatment options for Raynaud’s phenomenon are extremely limited and ineffective in most patients. Researchers at the University of Minnesota have developed a medical device for the non-pharmaceutical treatment of Raynaud’s Phenomenon. A light treatment unit causes vasorelaxation to occur by exposing hands, or other parts of the body, to specific wavelengths of blue light and heat. This reverses the spasming of arteries and restores blood flow.
Phase of Development
TRL: 1-2Prototype in development.
Desired Partnerships
This technology is now available for:- License
- Sponsored research
- Co-development
Please contact our office to share your business’ needs and learn more.
Researchers
- Steven Saliterman, MD Adjunct Professor, Department of Biomedical Engineering
- Jerry Molitor, MD, PhD Professor of Medicine, Division of Rheumatic and Autoimmune Diseases